Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Lai

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|August 27, 2014
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacyDavid E Piccioni, Albert Lai
Neuromodulation : Journal of the International Neuromodulation Society|August 18, 2018
Sacral Burst Neuromodulation via Caudal Approach as a Treatment for Chronic CoccydyniaDavid W Lee, Albert Lai
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
Thin client performance for remote 3-D image displayAlbert Lai, Jason Nieh, Andrew Laine, et al.
Pediatric Investigation|March 22, 2024
Will artificial intelligence widen the therapeutic gap between children and adults?Matthew Nagy, Bryan Sisk, Albert Lai, et al.
Future Oncology (London, England)|August 17, 2012
Bevacizumab as first-line therapy for glioblastomaDavid Piccioni, Albert Lai, Phioanh Nghiemphu, et al.
Reports (MDPI)|July 30, 2025
The Durability and Efficacy of Cryopreserved Human Umbilical Cord Tissue Allograft for the Supplementation of Cartilage Defects Associated with the Sacroiliac Joint: A Case SeriesAlbert Lai, Jon Shou, Steve A Traina, et al.
Journal of Neuro-Oncology|August 25, 2012
A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomasPhioanh Leia Nghiemphu, Albert Lai, Richard M Green, et al.
Pharmacogenomics and Personalized Medicine|December 11, 2012
Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumabNaveed Wagle, Leia Nghiemphu, Albert Lai, et al.
Journal of Biomedical Informatics|March 11, 2014
Time motion studies in healthcare: what are we talking about?Marcelo Lopetegui, Po-Yin Yen, Albert Lai, et al.
Neuro-Oncology|September 25, 2008
The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivityMaya Remington, Jana Chtchetinin, Karen Ancheta, et al.
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|August 27, 2014
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacyDavid E Piccioni, Albert Lai
Neuromodulation : Journal of the International Neuromodulation Society|August 18, 2018
Sacral Burst Neuromodulation via Caudal Approach as a Treatment for Chronic CoccydyniaDavid W Lee, Albert Lai
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
Thin client performance for remote 3-D image displayAlbert Lai, Jason Nieh, Andrew Laine, et al.
Pediatric Investigation|March 22, 2024
Will artificial intelligence widen the therapeutic gap between children and adults?Matthew Nagy, Bryan Sisk, Albert Lai, et al.
Future Oncology (London, England)|August 17, 2012
Bevacizumab as first-line therapy for glioblastomaDavid Piccioni, Albert Lai, Phioanh Nghiemphu, et al.
Reports (MDPI)|July 30, 2025
The Durability and Efficacy of Cryopreserved Human Umbilical Cord Tissue Allograft for the Supplementation of Cartilage Defects Associated with the Sacroiliac Joint: A Case SeriesAlbert Lai, Jon Shou, Steve A Traina, et al.
Journal of Neuro-Oncology|August 25, 2012
A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomasPhioanh Leia Nghiemphu, Albert Lai, Richard M Green, et al.
Pharmacogenomics and Personalized Medicine|December 11, 2012
Update and developments in the treatment of glioblastoma multiforme - focus on bevacizumabNaveed Wagle, Leia Nghiemphu, Albert Lai, et al.
Journal of Biomedical Informatics|March 11, 2014
Time motion studies in healthcare: what are we talking about?Marcelo Lopetegui, Po-Yin Yen, Albert Lai, et al.
Neuro-Oncology|September 25, 2008
The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivityMaya Remington, Jana Chtchetinin, Karen Ancheta, et al.
Pageof 21